| Price | 1,840.80p on 30-03-2026 at 19:16:22 |
|---|---|
| Change | 27.20p 1.5% |
| Buy | 1,846.00p |
| Sell | 1,841.20p |
| Last Trade: | Buy 517.00 at 1,839.293p |
| Day's Volume: | 1,007 |
| Last Close: | 1,843.60p |
| Open: | 1,830.40p |
| ISIN: | IE00BDR5GV14 |
| Day's Range | 1,830.40p - 1,840.80p |
| 52wk Range: | 1,422.80p - 1,940.00p |
| Market Capitalisation: | £N/A |
| VWAP: | 1,837.21636p |
| Shares in Issue: | N/A |
Ubs Etf Gene (GENE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 517 | 1,839.293p | Suspected BUY Trade |
15:14:01 - 30-Mar-26 |
| Sell* | 129 | 1,836.279p | Negotiated Trade |
15:14:00 - 30-Mar-26 |
| Buy* | 145 | 1,840.80p | Automatic Execution |
14:39:53 - 30-Mar-26 |
| Sell* | 216 | 1,830.40p | Automatic Execution |
13:36:20 - 30-Mar-26 |
| Buy* | 60 | 1,816.788p | Suspected BUY Trade |
15:13:56 - 27-Mar-26 |
| Sell* | 110 | 1,813.785p | Negotiated Trade |
15:13:55 - 27-Mar-26 |
| Buy* | 56 | 1,821.40p | Automatic Execution |
13:24:26 - 27-Mar-26 |
| Sell* | 21 | 1,819.00p | Automatic Execution |
12:54:15 - 27-Mar-26 |
| Buy* | 498 | 1,831.014p | Suspected BUY Trade |
15:15:22 - 26-Mar-26 |
| Sell* | 1 | 1,827.092p | Negotiated Trade |
15:15:20 - 26-Mar-26 |
Ubs Etf Gene (GENE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Mar 2026 10:41 am | RNS | Net Asset Value(s) |
| 27th Mar 2026 11:57 am | RNS | Net Asset Value(s) |
| 26th Mar 2026 11:15 am | RNS | Net Asset Value(s) |
| 25th Mar 2026 11:43 am | RNS | Net Asset Value(s) |
| 24th Mar 2026 10:58 am | RNS | Net Asset Value(s) |
| 23rd Mar 2026 11:48 am | RNS | Net Asset Value(s) |
| 20th Mar 2026 11:08 am | RNS | Net Asset Value(s) |
| 19th Mar 2026 12:59 pm | RNS | Net Asset Value(s) |
| 18th Mar 2026 10:27 am | RNS | Net Asset Value(s) |
| 17th Mar 2026 10:16 am | RNS | Net Asset Value(s) |